Inter-relationships of plasma fibrinogen, low-density lipoprotein cholesterol, cigarette smoking and the prevalence of cardiovascular disease

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 3, Issue 3, 1996, Pages 307-312

  Fowkes, F Gerald R ^a   Lee, Amanda J ^a   Lowe, Gordon D O ^b   Riemersma, Rudolph A ^a   Housley, Edward ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

atherosclerosis; cholesterol; coronary heart disease; fibrinogen; smoking

Indexed keywords

FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0029832279     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679600300308     Document Type: Article

References (22)

1. Kagan A Kannel WB Dawber TR Revoltskie N: The coronary profile Ann N Y Acad Sci 1963, 97: 883-894.
2. Meade TW Mellows S Brozovic M Miller GJ Chakrabarti RR North WR etal: Haemostatic function and ischaemic heartdisease: Principal results of the Northwick Park Heart Study Lancet 1986, ii: 533-537.
3. Wilhemsen L Svardsudd K Korsan-Bengtsen K Larsson B Welin L Tibblin G: Fibrinogen as a risk factor for stroke andmyocardial infarction N Engl J Med 1984, 311: 501-505.
4. Stone MC Thorp JM: Plasma fibrinogen'a major coronaryrisk factor J R Coll Gen Pract 1985, 35: 565-569.
5. Kannel WB d'Agostino RB Belanger AJ: Fibrinogen, cigarette smoking, and risk ofcardiovascular disease: Insights from the Framingham Study Am Heart J 1987, 113: 1006-1008.
6. Heinrich J Balleisen L Schulte H Assmann G van de Loo J: Fibrinogen and factor VII in the prediction ofcoronary risk: Results from the PROCAM Study in healthy men Arterioscler Thromb 1994, 14: 54-59 and 1392(correction).
7. Cremer P Nagel D Bottcher B Seidel D: Fibrinogen: A coronary risk factor [in German] Diagnose Labor 1992, 42: 28-35.
8. Ernst E Resch KL: Fibrinogen as a cardiovascular risk factor: Ametaanalysis and review of the literature Ann Intern Med 1993, 118: 956-963.
9. Lowe GDO Fowkes FGR Dawes J Donnan PT Lennie SE Housley E: Blood viscosity, fibrinogen and activation ofcoagulation and leukocytes in peripheral arterial disease and the normalpopulation in the Edinburgh Artery Study Circulation 1993, 87: 1915-1920.
10. Rose GA: The diagnosis of ischaemic heart pain andintermittent claudication in field surveys Bull WHO 1962, 27: 645-658.
11. Fowkes FGR Housley E Cawood EHH Macintyre CCA Ruckley CV Prescott RJ: Edinburgh Artery Study: Prevalence ofasymptomatic and symptomatic peripheral arterial disease in the generalpopulation Int J Epidemiol 1991, 20: 384-392.
12. Prineas RJ Crow RS Blackburn H: The Minnesota Code Manual of ElectrocardiographicFindings. Boston: John Wright PSG, Inc.; 1982.
13. Lowe GDO Wood DA Douglas JT Riemersma RA Macintyre CC Tasase T: Relationships of plasma viscosity, coagulationand fibrinolysis to coronary risk factors and angina Thromb Haemost 1991, 65: 339-343.
14. Fowkes FGR: The measurement of atherosclerotic peripheralarterial disease in epidemiological surveys Int J Epidemiol 1988, 17: 201-207.
15. Shaper AG Cook DG Walker M Macfarlane PW: Recall of diagnosis by men with ischaemic heartdisease Br Heart J 1984, 51: 606-611.
16. Meade TW Imeson J Stirling Y: Effects of changes in smoking and othercharacteristics on clotting factors and the risk of ischaemic heart disease Lancet 1987, ii: 986-988.
17. Meade TW North WRS Chakrabarti R Haines AP Stirling Y: Population-based distributions of haemostaticvariables Br Med Bull 1977, 33: 283-288.
18. Bovill EG McDonagh J Triplett DA Arkin CF Brandt JT Hayes TE: Performance characteristics of fibrinogen assays Arch Pathol Lab Med 1993, 117: 58-66.
19. Smith FB Lowe GDO Fowkes FGR Rumley A Rumley AG Donnan PT Arkin CF Brardt JT Hayes TE: Smoking, haemostatic factors and lipid peroxidesin a population case control study of peripheral arterial disease Atherosclerosis 1993, 102: 155-162.
20. Lowe GDO: Blood rheology, haemostasis and vasculardisease. In Haemostasis and Thrombosis. 3rd edn. Edited by Bloom AL Forbes CD Thomas DP Tuddenham EGD. Edinburgh: ChurchillLivingstone; 1994: 1169-1188.
21. Hamsten A Wiman B: Fibrinolysis and atherosclerotic cardiovasculardisease In Atherosclerotic Cardiovascular Disease,Hemostasis, and Endothelial Function. Edited by Francis RB. New York: Dekker; 1992: 131-140.
22. Iso H Folsom AR Satos S Wu KK Shimamoto T Koike K: Plasma fibrinogen and its correlates in Japaneseand US population samples Arterioscler Thromb 1993, 13: 783-790.